Community-acquired pneumonia historical perspective

Jump to navigation Jump to search

Pneumonia Main Page

Community-Acquired Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Community-acquired pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Severity Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Ultrasound

Other Diagnostic Studies

Treatment

Hospital Admission Decision

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Community-acquired pneumonia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Community-acquired pneumonia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Community-acquired pneumonia historical perspective

CDC on Community-acquired pneumonia historical perspective

Community-acquired pneumonia historical perspective in the news

Blogs on Community-acquired pneumonia historical perspective

Directions to Hospitals Treating Community-acquired pneumonia

Risk calculators and risk factors for Community-acquired pneumonia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Sir William Osler, known as "the Father of Modern Medicine," appreciated the morbidity and mortality of pneumonia, describing it as the "Captain of the Men of Death" in 1918. However, several key developments in the 1900s improved the outcome for those with pneumonia. With the arrival of: penicillin and other antibiotics; modern surgical techniques; and intensive care in the twentieth century, mortality from pneumonia dropped precipitously in the developed world. Vaccination of infants against Haemophilus influenzae type b began in 1988 and led to a dramatic decline in cases shortly thereafter.[1] Vaccination against Streptococcus pneumoniae in adults began in 1977, and it began in children in 2000, resulting in a similar decline.[2]

Historical Perspective

The symptoms of pneumonia were described by Hippocrates (c. 460 BC–380 BC) as:

Peripneumonia, and pleuritic affections, are to be thus observed: If the fever be acute, and if there be pains on either side, or in both, and if expiration be if cough be present, and the sputa expectorated be of a blond or livid color, or likewise thin, frothy, and florid, or having any other character different from the common... When pneumonia is at its height, the case is beyond remedy if he is not purged, and it is bad if he has dyspnoea, and urine that is thin and acrid, and if sweats come out about the neck and head, for such sweats are bad, as proceeding from the suffocation, rales, and the violence of the disease which is obtaining the upper hand.

However, Hippocrates himself referred to pneumonia as a disease "named by the ancients." He also reported the results of surgical drainage of empyemas. Maimonides (1138–1204 AD) observed "The basic symptoms which occur in pneumonia and which are never lacking are as follows: acute fever, sticking pleuritic pain in the side, short rapid breaths, serrated pulse and cough."[3] This clinical description is quite similar to those found in modern textbooks, and it reflects the extent of medical knowledge during the Middle Ages into the 19th century.

Edwin Klebs was the first to see Bacteria in the airways of individuals who died from pneumonia in 1875.[4] Initial work performed by Carl Friedländer[5] and Albert Fränkel (1848-1916)[6] in 1882 and 1884, respectively, identified the two common bacterial causes Streptococcus pneumoniae and Klebsiella pneumoniae. Friedländer's initial work introduced the Gram stain, a fundamental laboratory test still used to identify and categorize bacteria. Christian Gram's paper describing the procedure in 1884 helped differentiate the two different bacteria and showed that pneumonia can be caused by more than one microorganism.[7]

Early Classification Schemes

Pneumonia can be classified in several ways. Pathologists originally classified the different forms according to the anatomic changes that were found in the lungs during autopsies. As more became known about the microorganisms causing pneumonia, a microbiologic classification arose, and with the advent of x-rays, a radiological classification was created as well. Another important system of classification is the combined clinical classification, which combines factors such as: age, risk factors for certain microorganisms, the presence of underlying lung disease and underlying systemic disease, and whether or not the person has recently been hospitalized.

Initial descriptions of pneumonia focused on the anatomic or pathologic appearance of the lung, either by direct inspection during autopsy or by its appearance under a microscope.

  • Lobar pneumonia is an infection that only involves a single lobe, or section, of a lung. Lobar pneumonia is often due to Streptococcus pneumoniae.
  • Multilobar pneumonia involves more than one lobe, and it often causes a more severe illness.
  • Interstitial pneumonia involves the areas in between the alveoli, and it may be called "interstitial pneumonitis". It is more likely to be caused by viruses or by atypical bacteria.

The discovery of x-rays made it possible to determine the anatomic type of pneumonia without direct examination of the lungs during autopsy; this led to the development of a radiological classification. Early investigators distinguished between typical lobar pneumonia and atypical (e.g. Chlamydophila) or viral pneumonia using the location, distribution, and the appearance of the opacities they saw on chest X-rays. Certain X-ray findings can be used to help predict the course of illness, although it is not possible to clearly determine the microbiologic cause of a pneumonia with X-rays alone.

References

  1. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.JAMA1993;269:221-6. PMID 8417239
  2. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of pneumococcal protein-polysaccharide conjugate vaccine. New Engl J Med. 2003;348:1737–1746. PMID 12724479
  3. Maimonides, Fusul Musa ("Pirkei Moshe").
  4. Klebs E. Beiträge zur Kenntniss der pathogenen Schistomyceten. VII Die Monadinen. Arch. exptl. Pathol. Parmakol. 1875 Dec 10;4(5/6):40–488.
  5. Friedländer C. Über die Schizomyceten bei der acuten fibrösen Pneumonie. Virchow's Arch pathol. Anat. u. Physiol. 1882 Feb 4;87(2):319–324.
  6. Fraenkel A. Über die genuine Pneumonie, Verhandlungen des Congress für innere Medicin. Dritter Congress. 1884 April 21;3:17–31.
  7. Gram C. Über die isolierte Färbung der Schizomyceten in Schnitt- und Trocken-präparaten. Fortschr. Med. 1884 March 15;2(6):185–189.